Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer

Journal of Urology

Volumn 158, Issue 1, 1997, Pages 23-30

  Zelefsky, Michael J ^a   Whitmore Jr , Willet F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Iodine isotopes; Prostatic neoplasms; Radiotherapy

Indexed keywords

IODINE 125;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; HUMAN; IMPLANTATION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RADIOISOTOPE THERAPY; SURGICAL APPROACH;

EID: 0030947222     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199707000-00005     Document Type: Article

References (37)

1. Paschkis, R. and Tittinger, W.: Radiumbehandlung eines prostatasarkoms Wein. Klin. Woschr., 23: 1715, 1910.
2. Carlton C. E., Jr. and Scardino, P. T.: Long-term results after combined radioactive gold seed implantation and external beam radiotherapy for localized prostatic cancer. In: A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer. Edited by D. S. Coffey, M. I. Resnick, F. A. Dorr and J. P. Karr. New York: Plenum Press, pp. 109-121, 1988.
3. Whitmore, W. F., Jr.: The rationale and results of ablative surgery for prostatic cancer. Cancer, 16: 1119, 1963.
4. Whitmore, W. F., Jr., Hilaris, B. and Grabstald, H.: Retropubic implantation of iodine 125 in the treatment of prostate cancer. J. Urol., 108: 918-922, 1972.
5. Anderson, L. L.: Spacing nomograph for interstitial implants of 1251 seeds. Med. Phys., 3: 48, 1976.
6. Kaplan, E. L. and Meir, P.: Nonparametric estimations from incomplete observations. J. Amer. Stat. Ass., 53: 457, 1958.
7. Yates, F.: The analysis of multiple classifications with unequal number in the different classes. J. Amer. Stat. Ass., 29: 51, 1934.
8. Cox, D. R.: Regression models and life tables. J. Roy. Stat. Soc. B., 34: 187, 1972.
9. Fuks, Z., Leibel, S. A., Wallner, K. E., Begg, C. B., Fair, W. R., Anderson, L. L., Hilaris, B. S. and Whitmore, W. F.: The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int. J. Rad. Oncol. Biol. Phys., 21: 537, 1991.
10. Bagshaw, M. A., Cox, R. S. and Ray, G. R.: Status of radiation treatment of prostate cancer at Stanford University. NCI Monogr., 7: 47, 1988.
11. Bagshaw, M. A., Cox, R. S. and Ramback, J. E.: Radiation therapy for localized prostate cancer. Justification by long-term follow-up. Urol. Clin. N. Amer., 17: 787, 1990.
12. Kaplan, I. D., Prestidge, B. R., Bagshaw, M. A. and Cox, R. S.: The importance of local control in the treatment of prostatic cancer. J. Urol., 147: 917, 1992.
13. Duncar, W., Warde, P., Catton, C. N., Munro, A. J., Lakier, R., Gadalla, T. and Gospodarowicz, M. K.: Carcinoma of the prostate: results of radical radiotherapy (1970-1985). Int. J. Rad. Oncol. Biol. Phys., 26: 203, 1993.
14. Perez, C. A., Pilepich, M. V., Garcia, D., Simpson, J. R., Zivnuska, F. and Hederman, M. A.: Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: experience at the Mallinckrodt Institute of Radiology. NCI Monogr., 7: 85, 1988.
15. Hahn, P., Baral, E., Cheang, M., Kostyra, J. and Roelss, R.: Long-term outcome of radical radiation therapy for prostatic carcinoma: 1967-1987. Int. J. Rad. Oncol. Biol. Phys., 34: 41, 1996.
16. Hanks, G. E., Asbell, S., Krall, J. M., Perez, C. A., Doggett, S., Rubin, P., Sause, W. and Pilepich, M. V.: Outcome for lymph node dissection negative T1-b, T2 (A-2,B) prostate cancer treated with external beam irradiation in RTOG 77-06. Int. J. Rad. Oncol. Biol. Phys., 21: 1099, 1991.
17. Lee, R. J. and Sause, W. T.: Surgically staged patients with prostatic carcinoma treated with definitive radiotheraphy: fifteen-year results. Urology, 43: 640, 1994.
18. Kuban, D. A., el-Mahdi, A. M. and Schellhammer, P. F.: I-125 interstitial implantation for prostate cancer. What have we learned 10 years later? Cancer, 63: 2415, 1989.
19. Lerner, S. P., Seale-Hawkins, C., Carlton, C. E., Jr. and Scardino, P. T.: The risk of dying of prostate cancer in patients with clinically localized disease. J. Urol., 146: 1040, 1991.
20. Lepor, H. and Walsh, P. C.: Long-term results of radical prostatectomy in clinically localized prostate cancer: experience at the Johns Hopkins Hospital. NCI Monogr., 7: 117, 1988.
21. Walsh, P. C. and Jewett, H. J.: Radical surgery for prostatic cancer. Cancer, 45: 1906, 1980.
22. Paulson, D. F., Moul, J. W. and Walther, P. J.: Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. J. Urol., 144: 1180, 1990.
23. Gibbons, R. P., Correa, R. J., Jr., Brannen, G. E. and Weissman, R. M.: Total prostatectomy for clinically localized prostatic cancer: long-term results. J. Urol., 141: 564, 1989.
24. Wallner, K: Iodine 125 brachytherapy for early stage prostate cancer: new techniques may achieve better results. Oncology, 5: 115, 1991.
25. Morton, J. D. and Peschel, R. E.: Iodine-125 implants versus external beam therapy for stages A2, B and C prostate cancer. Int. J. Rad. Oncol. Biol. Phys., 14: 1153, 1988.
26. Blasko, J. C., Wallner, K., Grimm, P. D. and Ragde, H.: Prostate specific antigen based disease control following ultrasound guided 125-iodine implantation for stage T1/T2 prostatic carcinoma. J. Urol., 154: 1096, 1995.
27. Wallner, K., Roy, J. and Harrison, L.: Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J. Clin. Oncol., 14: 449, 1996.
28. Ling, C. C.: Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model. Int. J. Rad. Oncol. Biol. Phys., 23: 81, 1992.
29. Shipley, W. U., Verhey, L. J., Munzenrider, J. E., Suit, H. D., Urie, M. M., McManus, P. L., Young, R. H., Shipley, J. W., Zeitman, A. L., Biggs, P. J., Heney, N. M. and Goiten, M.: Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int. J. Rad. Oncol. Biol. Phys., 32: 3, 1995.
30. Killian, C. S., Emrich, L. J., Vargas, F. P., Yang, N., Wang, M. C., Priore, R. L., Murphy, G. P. and Chu, T. M.: Relative reliability of five serially measured markers for prognosis of progression in prostate cancer. J. Natl. Cancer Inst., 76: 179, 1986.
31. Kaplan, I., Prestidge, B. R., Cox, R. S. and Bagshaw, M. A.: Prostate specific antigen after irradiation for prostatic carcinoma. J. Urol., 144: 1172, 1990.
32. Tjaden, H. B., Culp, D. A. and Flocks, R. H.: Clinical adenocarcinoma of the prostate in patients under 50 years of age. J. Urol., 93: 618, 1965.
33. Johnson, D. E., Lanieri, J. P., Jr. and Ayala, A. G.: Prostatic adenocarcinoma occurring in men under 50 years of age. J. Surg. Oncol., 4: 207, 1972.
34. Aprikian, A. G., Zhang, Z. F. and Fair, W. R.: Prostate adenocarcinoma in men younger than 50 years. A retrospective review of 151 patients. Cancer, 74: 1768, 1994.
35. Harrison, G. S. M.: The prognosis of prostatic cancer in the younger man. Brit. J. Urol., 55: 315, 1983.
36. Smedley, H. M., Sinnott, M., Freedman, L. S., Macaskill, P., Naylor, C. P. and Pillers, E. M.: Age and survival in prostatic carcinoma. Brit. J. Urol., 55: 529, 1983.
37. Benson, M. C., Kaplan, S. A. and Olsson, C. A.: Prostate cancer in men less than 45 years old: influence of stage, grade and therapy. J. Urol., 137: 888, 1987.